Newsroom Voices Saniona begins 2022 with three clinical trials ongoing January 4, 2022 | Source BioStock The Potential Of Ion Channel-Based Therapeutics September 8, 2021 | Source Cell & Gene Saniona – FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity August 19, 2021 | Source Health Professional Radio [ENG]
Saniona begins 2022 with three clinical trials ongoing January 4, 2022 | Source BioStock The Potential Of Ion Channel-Based Therapeutics September 8, 2021 | Source Cell & Gene Saniona – FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity August 19, 2021 | Source Health Professional Radio [ENG]
Saniona – FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity August 19, 2021 | Source Health Professional Radio [ENG]
